SEC Form 4/A · accession 0001127602-15-027802
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Katherine J Klein
Director
Period of report
Jun 26, 2015
Accepted (ET)
Sep 29, 2015 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2,F1,F3 | $175.43 | Jun 26, 2015 | A | 15,000 | A | Jun 26, 2016 | Jun 26, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1This award of stock options was originally reported on a Form 4 filed on June 29, 2015, which incorrectly reported the exercise price as $175.27 due to a clerical error.
- F2Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders.
- F3Awards becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.